Application segmentation in the Multimodality Radiation Shielding market is critical to understanding demand dynamics. The primary segments include Diagnostic Imaging and Therapeutic Radiation. Diagnostic Imaging, accounting for ~45% of the market, relies on shielding for X-ray, CT, and MRI equipment, driven by rising diagnostic procedures in hospitals and clinics. Therapeutic Radiation, representing ~55%, focuses on high-energy particle therapy and radiotherapy, where shielding complexity increases due to higher radiation intensity. These sub-segments shape the market size through distinct regulatory requirements, facility investments, and technology adoption rates. For instance, Therapeutic Radiation requires advanced materials like lead-free composites, while Diagnostic Imaging favors cost-effective modular solutions. This Multimodality Radiation Shielding segmentation highlights how application-specific needs influence material choices, innovation pipelines, and regional market growth.